ABIVAX launches IPO on the regulated market of Euronext in Paris

June 5, 2015
PDF Version
  • Share capital increase of €43.6 million, that can reach a maximum of €57.7 million after exercise of the Extension Clause and of the Overallotment Option
  • Subscription undertakings representing €33 million
  • Indicative price range: €18.26 - €24.34 per share
  • Placement period: from June 5 to June 22
  • Eligible for French PEA PME investment regime